Dr. Madoff on Selecting Patients With HCC Appropriate for Minimally Invasive Therapy

David C. Madoff, MD
Published: Monday, Mar 14, 2016



David C. Madoff, MD, professor of Radiology, vice chairman for Academic Affairs at Weill Cornell Medicine, discusses selecting patients with hepatocellular carcinoma (HCC) who are candidates for minimally invasive therapy.

Interventional oncologists work with multidisciplinary tumor boards in deciding a patient's treatment plan, Madoff explains, regarding surgery, radiation therapy, and medicine. Curative procedures are tailored for patients with cirrhosis and have small size tumors.

More palliative approaches are appropriate for patients with large tumor burden, where practitioners work to prolong survival and improve their quality of life.


David C. Madoff, MD, professor of Radiology, vice chairman for Academic Affairs at Weill Cornell Medicine, discusses selecting patients with hepatocellular carcinoma (HCC) who are candidates for minimally invasive therapy.

Interventional oncologists work with multidisciplinary tumor boards in deciding a patient's treatment plan, Madoff explains, regarding surgery, radiation therapy, and medicine. Curative procedures are tailored for patients with cirrhosis and have small size tumors.

More palliative approaches are appropriate for patients with large tumor burden, where practitioners work to prolong survival and improve their quality of life.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Emerging Treatment Options for Patients With High-Risk AMLMay 31, 20181.0
Oncology Briefings™: Updates in Pediatric Hepatic Veno-Occlusive Disease: Integrating Novel Therapeutic Strategies to Overcome Post-Transplant ObstaclesMay 31, 20181.0
Publication Bottom Border
Border Publication
x